Te Arai BioFarma Limited is a 100% privately owned New Zealand company making innovative medicines and medical products available to New Zealand, Australia and the Pacific Islands.
Message from our Chairman:
"Together the team at Te Arai BioFarma share a common mission to improve the health and productivity of Australasia through access to affordable medical products, in particular vaccines and other biologicals.
The inspiration and motivation for this mission comes from the legacy of our son, Zachary, who as a 22 year old student doctor died tragically of a vaccine preventable disease,
meningococcal C septicemia."
Te Arai Biofarma Chairman is Dr Lance Gravatt who has over a decade’s experience in research, including Oxford University, and over 20 years’ experience in the New Zealand pharmaceutical industry, including being CEO for one of New Zealand’s top prescription pharmaceutical companies. He has held the position of Vice-Chairman of the Researched Medicines Industry Association of New Zealand and is also a Director of a local farming business.
Director Jennifer Gravatt holds honours degrees in Planning and Social Sciences from the Universities of Auckland and Waikato. Jennifer is head of regulatory affairs and has several years’ experience working in various regulatory environments.
Director Scott Lissington is a graduate from the University of Auckland School of Business and the School of Medical and Health Sciences. Scott has worked in the pharmaceutical industry in New Zealand in sales and marketing roles. He has also been a New Zealand national representative rower and surf-boat rower.
Julia Reese is a graduate of the University of Waikato Management School. She has worked in the New Zealand pharmaceutical industry in both Sales and Regulatory roles.
Matt is a Chemistry & Marketing graduate of Otago universities Science and Commerce schools. Matt has experience in sales and marketing roles across a broad range of industries. Matt is our Australian based Specialist Product Manager in Sydney, NSW.
Named after a location in New Zealand of great significance to the company,
Te Arai derives from the Maori language meaning “barrier or shield” and symbolises the benefit of medicines in general and the protection provided by vaccines in particular for the prevention of infectious diseases.
Te Arai Biofarma is committed to maintaining long term collaborative and innovative relationships with significant global suppliers of health products.
Through partnering with leading distribution suppliers both locally and internationally, Te Arai Biofarma is committed to guaranteeing the highest standard of care is taken in bringing products from these suppliers to New Zealand.